Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 1, 2009, Pages 12-19

  Ognibene, D T ^a   Oliveira, P R B ^a   Marins De Carvalho, L C R ^a   Costa, C A ^a   Espinoza, L A ^b   Criddle, D N ^c   Tano, T ^a   Soares De Moura, R ^a   Resende, A C ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Angiotensin 1 7; Angiotensin II; AT2 receptors; Bradykinin; Hypertension; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BETA TUBULIN; BRADYKININ RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ICATIBANT; LOSARTAN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ACETYLCHOLINE; AGING; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; BRADYKININ; GENE EXPRESSION REGULATION; IMIDAZOLES; LOSARTAN; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PYRIDINES; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 2; VASODILATION;

EID: 58549083401     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05054.x     Document Type: Article

References (39)

1. Chung O, Unger T. Angiotensin II receptor blockade and end-organ protection. Am. J. Hypertens. 1999 12 : 150 6.
2. Simon G, Illyes G, Csiky B. Structural vascular changes in hypertension. Role of angiotensin II, dietary sodium supplementation, blood pressure, and time. Hypertension 1998 32 : 654 60.
3. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc. Res. 1998 40 : 352 63.
4. Rosendorff C. Vascular hypertrophy in hypertension: Role of the renin-angiotensin system. Mt Sinai J. Med. 1998 65 : 108 17.
5. Arima S, Endo Y, Yaoita H et al. The possible role of P450 metabolite of arachdonic acid in the vasodilator mechanism of the angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 1997 100 : 2816 23.
6. Endo Y, Arima S, Yaoita H, Tsunoda K, Omata K, Ito S. Vasodilation mediated by the angiotensin II type 2 receptor is impaired in the afferent arterioles of young spontaneously hypertensive rats. J. Vasc. Res. 1998 35 : 421 7.
7. Soares de Moura R, Carvalho LCRM, Emiliano AF, Resende AC. Vasodilator effect of angiotensin II in the isolated mesenteric vascular bed of the rat. Br. J. Pharmacol. 2001 133 : 101P (Abstract).
8. Kimura T, Toda N, Noda Y, Okamura T. Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries. J. Cardiovasc. Pharmacol. 2001 37 : 538 95.
9. 2 receptor-dependent vasodilation is mediated by the activation of vascular kinin generation under flow conditions. Br. J. Pharmacol. 2002 136 : 484 91.
10. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate the depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 1993 264 : 917 23.
11. Tsutsumi Y, Matsubara H, Masaki H et al. Angiotensin II type 2 receptor over expression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 1999 104 : 925 35.
12. 2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br. J. Pharmacol. 2004 141 : 860 6.
13. Cosentino F, Savoia C, De Paolis P et al. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am. J. Hypertens. 2005 18 : 493 9.
14. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005 111 : 1006 11.
15. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor response in the perfused mesenteric blood vessels of the rat. J. Physiol. 1965 177 : 21 30.
16. +]. A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 1993 21 : 423 9.
17. Resende AC, Ballejo G, Salgado MC. Role of non-nitric oxide non-prostaglandin endothelium-derived relaxing factor(s) in bradykinin vasodilation. Braz. J. Med. Biol. Res. 1998 31 : 1229 35.
18. Van der Loo B, Labugger R, Skepper JN et al. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 2000 18 : 1731 44.
19. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998 31 : 1248 54.
20. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000 36 : 957 64.
21. Li H, Witte K, August M et al. Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J. Am. Coll. Cardiol. 2006 47 : 2536 44.
22. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM. Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J. Cardiovasc. Pharmacol. 2005 45 : 136 43.
23. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999 33 : 366 72.
24. Diniz C, Leal S, Logan K et al. Immunohistochemical localization of angiotensin II receptor types 1 and 2 in the mesenteric artery from spontaneously hypertensive rats. Microsc. Res. Techn. 2007 70 : 677 81.
25. Bonnet F, Cooper ME, Carey RM, Casley D, Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: Influence of angiotensin II infusion. J. Hypertens. 2001 19 : 1075 81.
26. Hiyoshi H, Yayama K, Takano M, Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005 45 : 967 73.
27. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995 26 : 164 70.
28. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998 31 : 349 55.
29. 2 receptor-mediated hypotension. J. Hum. Hypertens. 2000 14 : 40 6.
30. Tirapelli CR, Fukada SY, de Godoy MA, de Oliveira AM. Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sci. 2006 78 : 2676 82.
31. Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 2006 48 : 316 22.
32. Sivieri Jr. DO, Bispo-da-Silva LB, Oliveira EB, Resende AC, Salgado MC. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Hypertension 2007 50 : 110 15.
33. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke 1993 24 : 2041 4.
34. Pörsti I, Bara AT, Busse R, Hecker M. The release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br. J. Pharmacol. 1994 111 : 652 4.
35. Ren Y, Garvin JL, Carretero OA. The vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002 39 : 799 802.
36. Santos RA, Simoes e Silva AC, Maric C et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl Acad. Sci. USA 2003 100 : 8258 63.
37. Santos RA, Campagnole-Santos MJ, Baracho NC et al. The characterisation of a new angiotensin antagonist selective for angiotensin-(1-7). Evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensins receptors. Brain Res. Bull. 1994 35 : 293 8.
38. Bayorth MA, Eatman D, Walton M, Socci RR, Thierry-Palmer M, Emmett N. A-779 attenuates the angiotensin-(1-7) depressor response in salt-induced hypertensive rats. Peptides 2002 23 : 57 64.
39. Oliveira MA, Fortes ZB, Santos RA, Kosla MC, De Carvalho MH. Synergistic effect of angiotensin (1-7) on bradykinin arteriolar dilation in vivo. Peptides. 1999 20 : 1195 201.